Investing
Top Analyst Upgrades and Downgrades (ACTV, AGN, BMY, CAG, COP, DUK, LLY, FRX, MRK, PFE, TIF, ULTA, WPI, YUM)
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday.
Active Network Inc. (NYSE: ACTV) raised to Buy at BofA/ML.
Allergan Inc. (NYSE: AGN) started as Buy at Citigroup.
Bristol-Myers Squibb Co. (NYSE: BMY) started as Neutral at Citigroup.
ConAgra Foods Inc. (NYSE: CAG) raised to Buy at Jefferies.
ConocoPhillips (NYSE: COP) started as Outperform at Wells Fargo.
Duke Energy Corp. (NYSE: DUK) maintained Outperform with $76.50 target at Credit Suisse.
Eli Lilly & Co. (NYSE: LLY) started as Buy at Citigroup.
Forest Laboratories Inc. (NYSE: FRX) started as Buy at Citigroup.
Merck & Co. (NYSE: MRK) started as Neutral at Citigroup.
Pfizer Inc. (NYSE: PFE) started as Buy at Citigroup.
Tiffany & Co. (NYSE: TIF) cut to Neutral at BofA/ML.
Ulta Salon Cosmetics & Fragrance Inc. (NASDAQ: ULTA) raised to Outperform at Wells Fargo.
Watson Pharmaceuticals Inc. (NYSE: WPI) reiterated Buy with $100 target and raised estimates at Argus.
Yum! Brands Inc. (NYSE: YUM) cut to Neutral at UBS and cut to Underperform at Raymond James.
JON C. OGG
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
